Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy

Gynecologic Oncology

Volumn 81, Issue 1, 2001, Pages 33-39

  Montz, F J ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cervical cytology; Endometrial cells

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; PROGESTERONE;

ADULT; AGED; ARTICLE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0035059245     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6106     Document Type: Article

References (28)

1. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors
2. Significance of normal endometrial cells detected by cervical cytology
3. Classification of endometrial cells on cervical cytology
4. Significance of endometrial cells in cervicovaginal smears
5. Significance of atypical endometrial cells detected by cervical cytology
6. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women
7. Endometrial carcinoma: The relevance of cervical cytology
8. The prognostic significance of cervico-vaginal cytology in endometrial cancer
9. Papanicolaou smears by the Bethesda System in endometrial malignancy: Utility and prognostic importance
10. The current efficacy of the cervical-vaginal cytosmear to detect endometrial cancer
11. Screening of asymptomatic women for endometrial cancer
12. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma
13. Cervical cytology in menopausal women at high risk for endometrial disease
14. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma
15. The Bethesda System for reporting cervical/vaginal diagnoses
16. Interobserver variability in subclassification of squamous intraepithelial lesions: Results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
17. Improving accuracy in gynecologic cytology: Results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
18. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
19. Endometrial disease after treatment with oestrogens and progestogens in the climacteric
20. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints
21. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women
22. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy
23. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progesten therapy in postmenopausal women
24. Continuous low dose combined hormone replacement therapy and the risk of endometrial cancer
25. Combined hormone replacement therapy and the risk of endometrial cancer: Preliminary report
26. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study): A randomized controlled trial
27. Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos?